Excellentcare Medical Supplies (Huizhou) Co., Ltd. and Shenzhen Hongxun Biomedical Technology Co., Ltd. officially reached a strategic cooperation on March 7, 2025, Excellentcare as the leading enterprise, cooperated two parties will focus on the "respiratory humidification therapy device", and through product cross sales, joint product development, and national channel collaboration, build a "equipment+consumables" integrated products deep cooperation in the respiratory therapy field.
Against the backdrop of accelerated transformation towards intelligence and precision in the healthcare industry, Excellentcare Medical and Hongxun Biomedical have decided to achieve strategic upgrading through technological complementarity and resource integration based on their profound insights into industry trends. Excellentcare Medical has a mature R&D system and global market layout in the high-end medical consumables and intelligent medical equipment field, while Hongxun Biomedical has formed unique competitiveness in segmented fields with its innovative advantages in medical equipment technology and digital medical solutions. This cooperation marks product cooperate a deep integration into the industrial chain, building an integrated solution covering "product research and development + clinical application + market services"jointly.
Two companies not only reduce operating costs and improve resource utilization efficiency through deep binding, but also enables develop more competitive new products and services by joint innovation, thereby establishing own competitive advantage in the market. Both parties can share customer base and expand market coverage. Combining brand influence with expertise in the field will attract more potential customers effectively, promote mutual growth in market share, and consolidate and expand market position.
The strategic cooperation is not just a commercial interests combination, also a mission and vision resonance. Through Excellentcare's medical consumables research and manufacturing expertise with Hongxun Biotechnology's medical equipment genes deep integration, two parties cooperate will accelerate the precision medical technology innovation. We look forward to creating higher health value for medical institutions and patients through the 'multiplication effect' resources.
